324 related articles for article (PubMed ID: 3100424)
1. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Thomas L; Naumann P; Crea A
Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
[TBL] [Abstract][Full Text] [Related]
2. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
Davies S; Sparham PD; Spencer RC
J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
Texier-Maugein J; Mormède M; Fourche J; Bébéar C
Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ciprofloxacin and ofloxacin against the Mycobacterium avium-intracellulare complex.
Johnson SM; Roberts GD
Diagn Microbiol Infect Dis; 1987 May; 7(1):89-91. PubMed ID: 3121243
[TBL] [Abstract][Full Text] [Related]
5. [Sensitivity of 7 mycobacterial species to new quinolones].
Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
[TBL] [Abstract][Full Text] [Related]
6. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
Rastogi N; Goh KS; David HL
Ann Inst Pasteur Microbiol; 1988; 139(2):233-7. PubMed ID: 3165641
[No Abstract] [Full Text] [Related]
7. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
[TBL] [Abstract][Full Text] [Related]
8. Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Heifets LB; Lindholm-Levy PJ
Tubercle; 1987 Dec; 68(4):267-76. PubMed ID: 3138801
[TBL] [Abstract][Full Text] [Related]
9. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
Saito H; Sato K; Tomioka H; Watanabe T
Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537
[No Abstract] [Full Text] [Related]
10. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
Young LS; Berlin OG; Inderlied CB
Am J Med; 1987 Apr; 82(4A):23-6. PubMed ID: 3107379
[TBL] [Abstract][Full Text] [Related]
11. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.
Trimble KA; Clark RB; Sanders WE; Frankel JW; Cacciatore R; Valdez H
J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096
[TBL] [Abstract][Full Text] [Related]
12. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
Casal M; Gutierrez J; Ruiz P; Moreno G
Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
[TBL] [Abstract][Full Text] [Related]
13. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
15. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
Dailloux M; Petitpain N; Henry C; Weber M
Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
[TBL] [Abstract][Full Text] [Related]
16. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid.
Casal MJ; Rodriguez FC; Luna MD; Benavente MC
Antimicrob Agents Chemother; 1987 Jan; 31(1):132-3. PubMed ID: 3105441
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of quinolones and macrolides against mycobacteria.
Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
[TBL] [Abstract][Full Text] [Related]
19. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the ofloxacin resistance of tubercle bacilli].
Tsukamura M; Mizuno S
Kekkaku; 1985 Oct; 60(10):517-21. PubMed ID: 3935845
[No Abstract] [Full Text] [Related]
[Next] [New Search]
